Evorel 1,6 mg/ 3,2 mg/ 4,8 mg/ 6,4 mg Transdermal patch.
PDF Leaflet Revision Date: 17 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of menopausal symptoms and prevention of post-menopausal osteoporosis.
Dosage (summary)
Apply twice weekly; initiate with EVOREL 50, adjust as needed.
Special Populations
- Elderly
- Liver impairment
- Kidney impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Barbiturates
- Carbamazepine
- Rifampicin
- St. John's wort
- Lamotrigine
Contraindications
- Hypersensitivity to estrogen
- Breast cancer
- Endometrial cancer
- Undiagnosed genital bleeding
- Active liver disease
- Thromboembolic disorders
Common side effects
- Headache
- Breast pain
- Nausea
- Dizziness
- Application site reactions
Counselling Points
- Apply to clean, dry skin
- Change patch every 3-4 days
- Report any unusual bleeding
- Avoid use during pregnancy
Serious warnings
- Increased risk of breast cancer
- Risk of thromboembolism
- Monitor for endometrial hyperplasia
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?